Please note that maintenance work is scheduled between 4 AM and 5 AM - CET.
During this time, you may experience reduced performance.
Thanks for your patience.
in (world ranking)
Patrizia Chiusolo
Hematology — Agostino Gemelli University Polyclinic, Italy
Patrizia Chiusolo
Joined Feb 2026
Agostino Gemelli University Polyclinic · Hematology
Top 1% Worldwide expert in Stem Cell Transplantation, Cell Transplantation, Leukemia
A Phase 1 2 study of Enzomenib (DSP 5336) in Patients with Acute leukemia 2022-502741-10-00 — hematologic neoplasms, leukemia, mutation
Phase 1/Phase 2
Recruiting
2024
A phase 2 multicentric study to assess the efficacy and safety of maribavir treatment in hematopoietic stem cell transplant (HSCT) recipients with cytomegalovirus (CMV) infection with a medical condition that contraindicate the administration of ganciclovir valganciclovir or foscarnet and in those who discontinued first line preemptive therapy with ganciclovir valganciclovir or foscarnet due to toxicity or intolerance 2025-521074-34-00 — cells, safety, microscopy, electron, scanning transmission, cytomegalovirus infections, ganciclovir, stem cells, cytomegalovirus, foscarnet, transplants, therapeutics, hematopoietic stem cells, antiviral agents, infections, valganciclovir
Phase 2
Recruiting
2026
Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History NCT06923670 — research design, genes, thrombocythemia, essential, polycythemia vera, thrombocytosis, hematologic neoplasms, multiple endocrine neoplasia type 1, neoplasms, epithelial cell adhesion molecule, polycythemia, prevalence, myeloproliferative disorders, genes, apc, history, genes, brca1, mutation, primary myelofibrosis
To provide the best experience, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent or withdrawal of consent may adversely affect certain features and functions.
Functional
Always active
Storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of transmitting a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
Storage or technical access used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles in order to send advertisements, or to track the user on a website or on several websites with similar marketing purposes.